Johnson Johnson (Mexico) Insiders

JNJ Stock  MXN 3,190  21.83  0.69%   
Johnson Johnson employs about 39 people. The company is managed by 29 executives with a total tenure of roughly 196 years, averaging almost 6.0 years of service per executive, having 1.34 employees per reported executive. Break down of Johnson Johnson's management performance can provide insight into the company performance.
Alex Gorsky  Chairman
Chairman, CEO, Chairman of Executive Committee and Chairman of Fin. Committee
Joaquin Duato  Chairman
Executive Vice President Worldwide Chairman - Pharmaceuticals
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Johnson Stock please use our How to Invest in Johnson Johnson guide.

Johnson Johnson Management Team Effectiveness

The company has return on total asset (ROA) of 0.0881 % which means that it generated a profit of $0.0881 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2414 %, meaning that it generated $0.2414 on every $100 dollars invested by stockholders. Johnson Johnson's management efficiency ratios could be used to measure how well Johnson Johnson manages its routine affairs as well as how well it operates its assets and liabilities.

Johnson Johnson Workforce Comparison

Johnson Johnson is rated second overall in number of employees category among its peers. The total workforce of Drug Manufacturers—General industry is currently estimated at about 175,828. Johnson Johnson adds roughly 39.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—General industry.
The company has Profit Margin (PM) of 0.19 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.27 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.27.

Johnson Johnson Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Johnson Johnson Price Series Summation is a cross summation of Johnson Johnson price series and its benchmark/peer.

Johnson Johnson Notable Stakeholders

A Johnson Johnson stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Johnson Johnson often face trade-offs trying to please all of them. Johnson Johnson's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Johnson Johnson's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Alex GorskyChairman, CEO, Chairman of Executive Committee and Chairman of Fin. CommitteeProfile
Joaquin DuatoExecutive Vice President Worldwide Chairman - PharmaceuticalsProfile
Jennifer TaubertExecutive Vice President - Worldwide Chairman, PharmaceuticalsProfile
Ashley McEvoyExecutive Vice President - Worldwide Chairman, Medical DevicesProfile
Thibaut MongonExecutive Vice President Worldwide Chairman, ConsumerProfile
Paulus StoffelsWorldwide Chairman of Pharmaceuticals, Chief Scientific Officer and Member of Executive CommitteeProfile
Michael SneedExecutive Vice President - Global Corporate Affairs and Chief Communication OfficerProfile
Kathryn WengelExecutive Vice President Chief Global Supply Chain OfficerProfile
Joseph WolkChief Financial Officer, Executive Vice PresidentProfile
Peter FasoloChief Human Resource Officer, Executive Vice PresidentProfile
Jennifer DoudnaIndependent DirectorProfile
Marillyn HewsonIndependent DirectorProfile
Mary BeckerleIndependent DirectorProfile
Ronald WilliamsIndependent DirectorProfile
Anne MulcahyLead Independent DirectorProfile
Ian DavisIndependent DirectorProfile
Mark McClellanIndependent DirectorProfile
Charles PrinceIndependent DirectorProfile
Michael UllmannVP, General Counsel and Member of Executive CommitteeProfile
A WashingtonIndependent DirectorProfile
Dirk BrinckmanChief OfficerProfile
Joseph CPAEx CFOProfile
Robert DeckerController OfficerProfile
James SwansonEx OfficerProfile
D DavisIndependent DirectorProfile
Hubert JolyIndependent DirectorProfile
Jessica MooreVP RelationsProfile
Elizabeth ForminardExec CounselProfile
Mark WeinbergerIndependent DirectorProfile

About Johnson Johnson Management Performance

The success or failure of an entity such as Johnson Johnson often depends on how effective the management is. Johnson Johnson management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Johnson management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Johnson management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Johnson Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. Johnson Johnson was founded in 1886 and is based in New Brunswick, New Jersey. JOHNSON JOHNSON operates under Drug ManufacturersGeneral classification in Mexico and is traded on Mexico Stock Exchange. It employs 136000 people.
Please note, the imprecision that can be found in Johnson Johnson's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Johnson Johnson. Check Johnson Johnson's Beneish M Score to see the likelihood of Johnson Johnson's management manipulating its earnings.

Johnson Johnson Workforce Analysis

Traditionally, organizations such as Johnson Johnson use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Johnson Johnson within its industry.

Johnson Johnson Manpower Efficiency

Return on Johnson Johnson Manpower

Revenue Per Employee2.4B
Revenue Per Executive3.3B
Net Income Per Employee460M
Net Income Per Executive618.7M

Additional Tools for Johnson Stock Analysis

When running Johnson Johnson's price analysis, check to measure Johnson Johnson's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Johnson Johnson is operating at the current time. Most of Johnson Johnson's value examination focuses on studying past and present price action to predict the probability of Johnson Johnson's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Johnson Johnson's price. Additionally, you may evaluate how the addition of Johnson Johnson to your portfolios can decrease your overall portfolio volatility.